BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Williamson G, Kerimi A. Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Biochem Pharmacol 2020;178:114123. [PMID: 32593613 DOI: 10.1016/j.bcp.2020.114123] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Jamal QMS. Antiviral Potential of Plants against COVID-19 during Outbreaks—An Update. IJMS 2022;23:13564. [DOI: 10.3390/ijms232113564] [Reference Citation Analysis]
2 Mafra D, Ugochukwu SA, Borges NA, Cardozo LFMF, Stenvinkel P, Shiels PG. Food for healthier aging: power on your plate. Crit Rev Food Sci Nutr 2022;:1-14. [PMID: 35959705 DOI: 10.1080/10408398.2022.2107611] [Reference Citation Analysis]
3 Radhakrishnan R, Rajendran S, Jeyamani J, Anand S. THE RATIONALE AND POTENCY OF KABASURAKUDINEER – A SIDDHA FORMULATED MEDICINE TO PREVENT AND CONTROL SARS-CoV-2. IJAR 2022. [DOI: 10.36106/ijar/3601901] [Reference Citation Analysis]
4 Schmidt D, Hakeem Said I, Ohl N, Sharifii M, Cotrell P, Kuhnert N. Investigating the interaction between dietary polyphenols, the SARS CoV-2 spike protein and the ACE-2 receptor. Food Funct 2022. [PMID: 35734946 DOI: 10.1039/d2fo00394e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Grajek M, Krupa-kotara K, Kobza J, Yanakieva A. Pre-Pandemic Dietary Assessment of Elderly Persons Residing in Nursing Homes—Silesia (Poland). Healthcare 2022;10:765. [DOI: 10.3390/healthcare10050765] [Reference Citation Analysis]
6 Keranmu A, Pan L, Yu H, Fu J, Liu Y, Amuti S, Han P, Ma S, Xu H, Zhang Z, Chen D, Yang F, Wang M, Wang Y, Xing N, Jiang J. The potential biological effects of quercetin based on pharmacokinetics and multi-targeted mechanism in vivo. Journal of Asian Natural Products Research. [DOI: 10.1080/10286020.2022.2045965] [Reference Citation Analysis]
7 Ali S, Alam M, Khatoon F, Fatima U, Elasbali AM, Adnan M, Islam A, Hassan MI, Snoussi M, De Feo V. Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights. Biomedicine & Pharmacotherapy 2022;147:112658. [DOI: 10.1016/j.biopha.2022.112658] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
8 Mohamed ME, Tawfeek N, Elbaramawi SS, Fikry E. Agathis robusta Bark Essential Oil Effectiveness against COVID-19: Chemical Composition, In Silico and In Vitro Approaches. Plants (Basel) 2022;11:663. [PMID: 35270131 DOI: 10.3390/plants11050663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Farmanpour-Kalalagh K, Beyraghdar Kashkooli A, Babaei A, Rezaei A, van der Krol AR. Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand. Front Plant Sci 2022;13:780257. [PMID: 35197994 DOI: 10.3389/fpls.2022.780257] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
10 A. Badria F. Research on Natural Phenolic Compounds in FAB-Lab: Nonconventional Industrial, Pharmaceutical, and Therapeutic Applications. Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications 2022. [DOI: 10.5772/intechopen.101446] [Reference Citation Analysis]
11 Vörös-Horváth B, Živković P, Bánfai K, Bóvári-Biri J, Pongrácz J, Bálint G, Pál S, Széchenyi A. Preparation and Characterization of ACE2 Receptor Inhibitor-Loaded Chitosan Hydrogels for Nasal Formulation to Reduce the Risk of COVID-19 Viral Infection. ACS Omega 2022;7:3240-53. [PMID: 35097308 DOI: 10.1021/acsomega.1c05149] [Reference Citation Analysis]
12 Soleymani S, Naghizadeh A, Karimi M, Zarei A, Mardi R, Kordafshari G, Esmaealzadeh N, Zargaran A. COVID-19: General Strategies for Herbal Therapies. J Evid Based Integr Med 2022;27:2515690X211053641. [PMID: 34985368 DOI: 10.1177/2515690X211053641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
13 Silva-beltrán NP, Balderrama-carmona AP, Gálvez-ruíz J, Umsza-guez MA, Bustos ER. Biotechnological Strategies in the Intervention and Treatment of COVID-19. Frontiers of COVID-19 2022. [DOI: 10.1007/978-3-031-08045-6_21] [Reference Citation Analysis]
14 Ma LL, Liu HM, Liu XM, Yuan XY, Xu C, Wang F, Lin JZ, Xu RC, Zhang DK. Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19. Eur J Med Chem 2021;226:113857. [PMID: 34628234 DOI: 10.1016/j.ejmech.2021.113857] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
15 Zahran EM, Sayed AM, Abdelwahab MF, Albohy A, Abdulrazik BS, Ibrahim AM, Bringmann G, Abdelmohsen UR. Identifying the specific-targeted marine cerebrosides against SARS-CoV-2: an integrated computational approach. RSC Adv 2021;11:36042-59. [PMID: 35492761 DOI: 10.1039/d1ra07103c] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Şimşek Y, Baran SS, Aslım B. In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals. J Mol Graph Model 2021;109:108038. [PMID: 34607208 DOI: 10.1016/j.jmgm.2021.108038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Shadrack DM, Vuai SAH, Sahini MG, Onoka I. In silico study of the inhibition of SARS-COV-2 viral cell entry by neem tree extracts. RSC Adv 2021;11:26524-33. [PMID: 35480004 DOI: 10.1039/d1ra04197e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Binette V, Côté S, Haddad M, Nguyen PT, Bélanger S, Bourgault S, Ramassamy C, Gaudreault R, Mousseau N. Corilagin and 1,3,6-Tri-O-galloy-β-D-glucose: potential inhibitors of SARS-CoV-2 variants. Phys Chem Chem Phys 2021;23:14873-88. [PMID: 34223589 DOI: 10.1039/d1cp01790j] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
19 Blanco-Salas J, Hortigón-Vinagre MP, Morales-Jadán D, Ruiz-Téllez T. Searching for Scientific Explanations for the Uses of Spanish Folk Medicine: A Review on the Case of Mullein (Verbascum, Scrophulariaceae). Biology (Basel) 2021;10:618. [PMID: 34356473 DOI: 10.3390/biology10070618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sonju JJ, Anwar MR, Azad MAK, Sultana UH, Niloy KK, Das S. Antiviral Effects of Asian Natural Products Targeting SARS, MERS, and COVID-19. COVID 2021;2. [DOI: 10.2174/2666796702666210127111918] [Reference Citation Analysis]
21 Taştemur Ş, Ataseven H. Quercetin in the treatment and prevention of COVID-19. Cumhuriyet Medical Journal 2021;43:100-116. [DOI: 10.7197/cmj.939856] [Reference Citation Analysis]
22 Di Pierro F, Derosa G, Maffioli P, Bertuccioli A, Togni S, Riva A, Allegrini P, Khan A, Khan S, Khan BA, Altaf N, Zahid M, Ujjan ID, Nigar R, Khushk MI, Phulpoto M, Lail A, Devrajani BR, Ahmed S. Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study. Int J Gen Med 2021;14:2359-66. [PMID: 34135619 DOI: 10.2147/IJGM.S318720] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 51.0] [Reference Citation Analysis]
23 Khodajou-Masouleh H, Shahangian SS, Rasti B. Reinforcing our defense or weakening the enemy? A comparative overview of defensive and offensive strategies developed to confront COVID-19. Drug Metab Rev 2021;:1-34. [PMID: 33980089 DOI: 10.1080/03602532.2021.1928686] [Reference Citation Analysis]
24 Augusti PR, Conterato GMM, Denardin CC, Prazeres ID, Serra AT, Bronze MR, Emanuelli T. Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19. J Nutr Biochem 2021;97:108787. [PMID: 34089819 DOI: 10.1016/j.jnutbio.2021.108787] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
25 Kim CH. Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents. Front Pharmacol 2021;12:590509. [PMID: 34122058 DOI: 10.3389/fphar.2021.590509] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
26 Abubakar MB, Usman D, El-Saber Batiha G, Cruz-Martins N, Malami I, Ibrahim KG, Abubakar B, Bello MB, Muhammad A, Gan SH, Dabai AI, Alblihed M, Ghosh A, Badr RH, Thangadurai D, Imam MU. Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies. Front Pharmacol 2021;12:629935. [PMID: 34012391 DOI: 10.3389/fphar.2021.629935] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
27 Saakre M, Mathew D, Ravisankar V. Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2. Beni Suef Univ J Basic Appl Sci 2021;10:21. [PMID: 33782651 DOI: 10.1186/s43088-021-00107-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
28 Jena S, Munusami P, Mm B, Chanda K. Computationally approached inhibition potential of Tinospora cordifolia towards COVID-19 targets. Virusdisease 2021;:1-13. [PMID: 33778129 DOI: 10.1007/s13337-021-00666-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
29 Omrani M, Keshavarz M, Nejad Ebrahimi S, Mehrabi M, McGaw LJ, Ali Abdalla M, Mehrbod P. Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines. Front Pharmacol 2020;11:586993. [PMID: 33679384 DOI: 10.3389/fphar.2020.586993] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 26.0] [Reference Citation Analysis]
30 Lobo-Galo N, Gálvez-Ruíz JC, Balderrama-Carmona AP, Silva-Beltrán NP, Ruiz-Bustos E. Recent biotechnological advances as potential intervention strategies against COVID-19. 3 Biotech 2021;11:41. [PMID: 33457170 DOI: 10.1007/s13205-020-02619-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
31 Fang C, Mei J, Tian H, Liou YL, Rong D, Zhang W, Liao Q, Wu N. CSF3 Is a Potential Drug Target for the Treatment of COVID-19. Front Physiol 2020;11:605792. [PMID: 33551833 DOI: 10.3389/fphys.2020.605792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
32 Fakhri S, Piri S, Majnooni MB, Farzaei MH, Echeverría J. Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach. Front Pharmacol 2020;11:621099. [PMID: 33708124 DOI: 10.3389/fphar.2020.621099] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
33 Gu YY, Zhang M, Cen H, Wu YF, Lu Z, Lu F, Liu XS, Lan HY. Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study. PLoS One 2021;16:e0245209. [PMID: 33444408 DOI: 10.1371/journal.pone.0245209] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 22.0] [Reference Citation Analysis]
34 Mitra SS, Nandy S, Dey A. Promising Plant-Based Bioactive Natural Products in Combating SARS-CoV2 Novel Corona (COVID-19) Virus Infection. Medicinal Plants for Lung Diseases 2021. [DOI: 10.1007/978-981-33-6850-7_22] [Reference Citation Analysis]
35 Rehman MFU, Fariha C, Anwar A, Shahzad N, Ahmad M, Mukhtar S, Farhan Ul Haque M. Novel coronavirus disease (COVID-19) pandemic: A recent mini review. Comput Struct Biotechnol J 2021;19:612-23. [PMID: 33398233 DOI: 10.1016/j.csbj.2020.12.033] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
36 Teodori L, Sestili P, Madiai V, Coppari S, Fraternale D, Rocchi MBL, Ramakrishna S, Albertini MC. MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti-COVID-19 Therapeutics. Front Pharmacol 2020;11:582003. [PMID: 33363465 DOI: 10.3389/fphar.2020.582003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
37 Mehrbod P, Hudy D, Shyntum D, Markowski J, Łos MJ, Ghavami S. Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus. Biomolecules 2020;11:E10. [PMID: 33374214 DOI: 10.3390/biom11010010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
38 Seoane R, Vidal S, Bouzaher YH, El Motiam A, Rivas C. The Interaction of Viruses with the Cellular Senescence Response. Biology (Basel) 2020;9:E455. [PMID: 33317104 DOI: 10.3390/biology9120455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
39 Agrawal PK, Agrawal C, Blunden G. Quercetin: Antiviral Significance and Possible COVID-19 Integrative Considerations. Natural Product Communications 2020;15:1934578X2097629. [DOI: 10.1177/1934578x20976293] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 19.0] [Reference Citation Analysis]
40 Bousquet J, Cristol JP, Czarlewski W, Anto JM, Martineau A, Haahtela T, Fonseca SC, Iaccarino G, Blain H, Fiocchi A, Canonica GW, Fonseca JA, Vidal A, Choi HJ, Kim HJ, Le Moing V, Reynes J, Sheikh A, Akdis CA, Zuberbier T; ARIA group. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies. Clin Transl Allergy 2020;10:58. [PMID: 33292691 DOI: 10.1186/s13601-020-00362-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
41 DI Pierro F, Khan A, Bertuccioli A, Maffioli P, Derosa G, Khan S, Khan BA, Nigar R, Ujjan I, Devrajani BR. Quercetin Phytosome® as a potential candidate for managing COVID-19. Minerva Gastroenterol (Torino) 2021;67:190-5. [PMID: 33016666 DOI: 10.23736/S2724-5985.20.02771-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
42 Paraiso IL, Revel JS, Stevens JF. Potential use of polyphenols in the battle against COVID-19.Curr Opin Food Sci. 2020;32:149-155. [PMID: 32923374 DOI: 10.1016/j.cofs.2020.08.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 33.5] [Reference Citation Analysis]